Biotech Values

[jq1234]

The results from the Alpharadin (radium-223 chloride) trial #msg-63944830 show that a bone targeted therapy (not an “anti-cancer” drug) can improve OS in CRPC patients with bone metastases.

I'd say Alpharadin is an anti-cancer drug.

Alpharadin, a radiopharmaceutical
whose active ingredient is based
on radium-223. This drug product
is deposited into areas of new bone
formation where it releases alpha radiation,
thereby attacking the bone
metastases.

Xgreva is different.